US$ 20.41
copper peptide ghk-cu clinical trial injection Injectable Peptides for Anti-Aging? A Dermatologist Explains GHK-CU – Research Peptide |
Description
Prompt peripheral nerve regeneration induced by a hierarchically aligned fibrin nanofiber hydrogel

1A, E, F)

This triple mechanism of action distinguishes retatrutide from existing approved therapies such as semaglutide (a GLP-1 receptor agonist) or tirzepatide (a dual GIP/GLP-1 receptor agonist)

Peer-review started: June 6, 2017 First decision: June 22, 2017 Article in press: November 28, 2017 P- Reviewer: Bourgoin SG, Fujita T S- Editor: Gong ZM L- Editor: A E- Editor: Ma YJ Contributor Information Antonija Duzel, Departments of Pharmacology and Pathology, Medical Faculty University of Zagreb, Zagreb 10000, Croatia
